We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,044 hedge funds and large institutions have $55.2B invested in Thermo Fisher Scientific in 2016 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 332 increasing their positions, 458 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more funds holding in top 10

Funds holding in top 10: 7893 (+15)

13% more call options, than puts

Call options by funds: $226M | Put options by funds: $201M

7% more capital invested

Capital invested by funds: $51.5B → $55.2B (+$3.71B)

0.13% less ownership

Funds ownership: 88.79%88.67% (-0.13%)

2% less first-time investments, than exits

New positions opened: 64 | Existing positions closed: 65

1% less funds holding

Funds holding: 1,0551,044 (-11)

28% less repeat investments, than reductions

Existing positions increased: 332 | Existing positions reduced: 458

Holders
1,044
Holders Change
-11
Holders Change %
-1.04%
% of All Funds
27.85%
Holding in Top 10
93
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+19.23%
% of All Funds
2.48%
New
64
Increased
332
Reduced
458
Closed
65
Calls
$226M
Puts
$201M
Net Calls
+$25.2M
Net Calls Change
-$33.8M
Name Holding Trade Value Shares
Change
Change in
Stake
SC
226
Stralem & Co
New York
$19.9M -$396K -2,570 -2%
ESCM
227
Echo Street Capital Management
New York
$19.9M +$1.03M +6,693 +6%
GF
228
Gabelli Funds
New York
$19.7M
TPSF
229
Texas Permanent School Fund
Texas
$19.3M -$963K -6,252 -5%
TCT
230
TIAA CREF Trust
Missouri
$19.3M +$95.5K +620 +0.5%
WSFS
231
Wilmington Savings Fund Society
Delaware
$19.2M -$140K -906 -0.7%
GIBU
232
Gulf International Bank (UK)
United Kingdom
$19.1M
GIA
233
Guyasuta Investment Advisors
Pennsylvania
$19.1M +$390K +2,529 +2%
SG
234
Swarthmore Group
Pennsylvania
$19M -$516K -3,350 -3%
WJA
235
Williams Jones & Associates
New York
$18.9M -$257K -1,666 -1%
Fiera Capital (Canada)
236
Fiera Capital (Canada)
Quebec, Canada
$18.9M +$1.78M +11,579 +11%
ACP
237
Ashfield Capital Partners
California
$18.7M -$1.76M -11,418 -9%
Asset Management One
238
Asset Management One
Japan
$18.4M +$489K +3,174 +3%
FA
239
Friess Associates
Delaware
$18.2M
RJA
240
Raymond James & Associates
Florida
$18.2M +$3.01M +19,537 +21%
ONB
241
Old National Bancorp
Indiana
$18.2M -$4.36M -28,316 -20%
UCFA
242
United Capital Financial Advisors
Texas
$18.1M -$325K -2,107 -2%
AP
243
Atwood & Palmer
Missouri
$18.1M -$127K -824 -0.7%
VRS
244
Virginia Retirement Systems
Virginia
$17.9M
SLAM
245
Swiss Life Asset Management
$17.8M +$453K +2,942 +3%
FQ
246
First Quadrant
California
$17.8M -$925 -6 -0%
Handelsbanken Fonder
247
Handelsbanken Fonder
Sweden
$17.6M -$291K -1,887 -2%
ASRS
248
Arizona State Retirement System
Arizona
$17.6M +$92.5K +600 +0.5%
Los Angeles Capital Management
249
Los Angeles Capital Management
California
$17.4M -$857K -5,563 -5%
PWAG
250
Polaris Wealth Advisory Group
California
$17.3M +$1.03M +6,669 +7%

TMO Hedge Fund Activity: Q3 2016 in Review

1,044 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2016, worth a combined $55.2B — up 7.2% from $51.5B a quarter earlier.

Sellers outnumbered buyers: 65 funds closed out of TMO and 64 opened new positions — a net loss of 1 holder — while 458 trimmed existing stakes and 332 added.

The largest buyer was Winslow Capital Management, opening a new position worth an estimated $290M. The largest seller was Capital Research Global Investors, cutting an estimated $250M.

  • 1,044 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2016, down from 1,055 in Q2 2016.
  • Funds reported $55.2B of Thermo Fisher Scientific stock for Q3 2016, up 7.2% quarter-over-quarter.
  • 64 funds opened new Thermo Fisher Scientific positions in Q3 2016 and 65 closed out, a net change of -1 holder.
  • The largest Thermo Fisher Scientific buyer in Q3 2016 was Winslow Capital Management, an estimated $290M added.
  • The largest Thermo Fisher Scientific seller in Q3 2016 was Capital Research Global Investors, an estimated $250M sold.

Based on aggregated 13F filings for Q3 2016.